N/A
Completed N=33
HPV DNA Testing Through Mobile Mammography Unit
Source: ClinicalTrials.gov NCT03551028 ↗Enrolled (actual)
33
Serious AEs
0.0%
Results posted
Nov 2024
Primary outcomePrimary: Acceptability of Self-Collection Paired With Mobile Mammography — 33 Participants
Summary
Invasive cervical cancer incidence and mortality can be dramatically reduced through early detection and treatment, but many women do not complete screening at recommended intervals. Many low-income women in Virginia remain uninsured and are at significant risk of being medically underserved and failing to complete regular cervical cancer screening. Self-collection of specimens for HPV testing is an innovative approach that may increase access to cervical cancer screening in populations that do not participate in traditional clinic-based screening. Innovative delivery models are needed to reach at-risk populations. This study seeks to explore the acceptability and feasibility of pairing self-collection of HPV samples for DNA testing with mobile mammography in women living in rural Virginia.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Acceptability of Self-Collection Paired With Mobile Mammography |
33 | — |
| PRIMARY Feasibility of Self-Collection for HPV Paired With Mobile Mammography |
33 | — |
Eligibility Criteria
Inclusion Criteria
- not pregnant
Exclusion Criteria
- history of hysterectomy or pelvic RT non English speaking
Data sourced from ClinicalTrials.gov (NCT03551028). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.